Home
About
Overview
Sharing Data
ORCID
Help
History (11)
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
The development of synapses in striate cortex of man.
Histamine antagonizes serotonin and growth factor-induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells.
Retrospective assessment of initial stroke severity with the Canadian Neurological Scale.
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients.
A safety assessment of crizotinib in the treatment of ALK-positive NSCLC patients. Expert Opin Drug Saf. 2015 Mar; 14(3):485-93.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Drug Interactions
Humans
Lung Neoplasms
Mutation
Protein Kinase Inhibitors
Pyrazoles
Pyridines
Quality of Life
Receptor Protein-Tyrosine Kinases
authors with profiles
Ravi Salgia